Clinical Trial Update: A Study of Atezolizumab in Combination With Nab-Paclitaxel Compared With Placebo With Nab-Paclitaxel for Participants With Previously Untreated Metastatic Triple-Negative Breast Cancer (IMpassion130) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating atezolizumab plus nab-paclitaxel vs placebo with nab-paclitaxel in previously untreated metastatic triple-negative breast cancer; trial…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Triple-negative Breast Cancer

Drugs mentioned

• Atezolizumab (atezolizumab)
• Nab-paclitaxel (paclitaxel protein-bound)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Triple Negative Breast Cancer | Phase 3 | Status: COMPLETED | Results posted: 2021-05-17